Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases

Brain metastases (BMs) are the most common type of brain tumor, and the incidence among breast cancer (BC) patients has been steadily increasing over the past two decades. Indeed, ~ 30% of all patients with metastatic BC will develop BMs, and due to few effective treatments, many will succumb to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Carney, Christine P., Pandey, Nikhil, Kapur, Anshika, Woodworth, Graeme F., Winkles, Jeffrey A., Kim, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568876/
https://www.ncbi.nlm.nih.gov/pubmed/34716900
http://dx.doi.org/10.1007/s13346-021-01039-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568876/
https://www.ncbi.nlm.nih.gov/pubmed/34716900
http://dx.doi.org/10.1007/s13346-021-01039-9

Ejemplares similares